Inventor · disambiguated record
Christopher W. Espelin
Also filed as: ESPELIN CHRISTOPHER · ESPELIN CHRISTOPHER W
1 granted patent·3 pending applications·0 citations·filing 2013–2017
10Inventor score
Files withMERRIMACK PHARMACEUTICALS INC4
Top patents by PatentIndex Score
4 records- 0149US2017080087A1Combination Therapies for Treating Her2-Positive Cancers that are Resistant to Her2-Targeted TherapiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0243US9913901B2Combination therapy for treating HER2-positive cancersMERRIMACK PHARMACEUTICALS INC·Filed 2013·Granted Mar 13, 2018·0 cites·22 claims
- 0339US2017258903A1Combination therapies for treating her2-positive cancers that are resistant to her2-targeted therapiesMERRIMACK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0437US2017022290A1Combination therapies for treating her2-positive cancersMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher W. Espelin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →